3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
4
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
1
Hematologic Neoplasms
1
Cardiovascular Diseases
1
Interventions
Blood Specimen Collection
56
Surveys and Questionnaires
51
Specimen Handling
30
Observation
18
Radiotherapy
15
Interviews as Topic
12
Magnetic Resonance Spectroscopy
11
Surgical Procedures, Operative
10
Data Collection
10
Watchful Waiting
9
Drug Therapy
9
Biopsy
9
darolutamide
8
Tomography, X-Ray Computed
8
palbociclib
7
Standard of Care
7
Magnetic Resonance Imaging
7
Immune Checkpoint Inhibitors
7
ribociclib
6
Patient Reported Outcome Measures
6
Bevacizumab
6
trastuzumab deruxtecan
5
Ultrasonography
5
Restraint, Physical
5
Radiofrequency Ablation
5
Mastectomy, Segmental
5
Mass Screening
5
Genetic Testing
5
Breath Tests
5
enzalutamide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Antineoplastic Agents
×
90 days
×
Clear all
NCT07621289
2026-06-02
EUCARTOXSCORES
University Hospital, Caen
Not yet recruiting
10,000 enrolled